Sunitinib Malate

Sunitinib Malate

Sunitinib Malate (SU 11248 Malate) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM for VEGFR2 and 2 nM for PDGFRβ. It inhibits autophosphorylation and RNase activation of Ire1α and selectively targets FLK1, PDGFRβ, and FLT3. Sunitinib reduces VEGF- and FGF-induced cell proliferation and tumor growth in xenograft models. Reagent grade, for research use only.

Molecular structure of the compound BP-43644
    • Unit
    • Price
    • Qty
    • 5 G
    • $120.00
    • 10 G
    • $210.00
    • 25 G
    • $380.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire